Jiaqing Xie

Benchmark gains in LLMs can be misleading, as they may reflect improved reachability rather than true capability expansion, with significant implications for performance evaluation.

ABOPD achieves a remarkable 0.42 Å reduction in RMSD for antibody CDR design, setting a new standard for structural fidelity in protein generation.

Learnable spectral positional encodings can achieve gauge invariance and outperform traditional methods, converging to optimal solutions in directed graph settings.